Back to Search Start Over

Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics

Authors :
Rong-Xin Qu
Ting-Ren Lu
Hong-Ying Wu
Da-Yong Lu
Source :
Reviews on Recent Clinical Trials. 12:101-110
Publication Year :
2017
Publisher :
Bentham Science Publishers Ltd., 2017.

Abstract

Background Last two to three decades, this world witnesses a rapid progress of biomarkers and bioinformatics technologies. Cancer bioinformatics is one of such important omics branches for experimental/clinical studies and applications. Methods Same as other biological techniques or systems, bioinformatics techniques will be widely used. But they are presently not omni-potent. Despite great popularity and improvements, cancer bioinformatics has its own limitations and shortcomings at this stage of technical advancements. Results This article will offer a panorama of bioinformatics in cancer researches and clinical therapeutic applications-possible advantages and limitations relating to cancer therapeutics. A lot of beneficial capabilities and outcomes have been described. As a result, a successful new era for cancer bioinformatics is waiting for us if we can adhere on scientific studies of cancer bioinformatics in malignant- origin mining, medical verifications and clinical diagnostic applications. Conclusion Cancer bioinformatics gave a great significance in disease diagnosis and therapeutic predictions. Many creative ideas and future perspectives are highlighted.

Details

ISSN :
15748871
Volume :
12
Database :
OpenAIRE
Journal :
Reviews on Recent Clinical Trials
Accession number :
edsair.doi.dedup.....f28642b3dc093b4b8cd2778f260dc448